The U.S. Food and Drug Administration (FDA) has raised concerns over manufacturing controls at a Teva Pharmaceutical Industries plant in China, Israel’s biggest company said in a regulatory filing on Thursday.
U.S. FDA raises concerns over Teva’s plant in China
Website developed in accordance with Web Content Accessibility Guidelines 2.1.
If you encounter any issues while using this site, please contact us: 516.579.6500
If you encounter any issues while using this site, please contact us: 516.579.6500
